There were 1,681 press releases posted in the last 24 hours and 359,336 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
BridgeBio Pharma Presents Updated Positive Data from its BBP-812 Canavan Disease Gene Therapy Program at the 51st Annual Meeting of the Child Neurology Society

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image